Gürses, K. Et Al. 2019. Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients.. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , vol.47 , 564-571.

Gürses, K., Yalçın, M., Koçyiğit, D., Canpınar, H., Ateş, A., Canpolat, U., ... Yorgun, H.(2019). Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients.. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , vol.47, 564-571.

Gürses, KM Et Al. "Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients.," Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , vol.47, 564-571, 2019

Gürses, KM Et Al. "Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients.." Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , vol.47, pp.564-571, 2019

Gürses, K. Et Al. (2019) . "Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients.." Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , vol.47, pp.564-571.

@article{article, author={KM Gürses Et Al. }, title={Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients.}, journal={Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir}, year=2019, pages={564-571} }